Fellos, a Netherlands-based digital men’s health clinic, has secured €650,000 in a pre-seed funding round, exceeding its initial target in a short period. The company, founded in 2024, offers digital healthcare solutions for conditions such as erectile dysfunction, hair loss, premature ejaculation, and acne. With this funding, Fellos plans to enhance its platform and extend its reach across Europe. The clinic connects patients with BIG-registered doctors and a Dutch partner pharmacy, providing consultations and prescriptions seamlessly. The growing demand for accessible healthcare solutions in men’s health has driven the company’s rapid expansion.
In previous discussions on digital healthcare, similar services have emerged to address gaps in accessibility and convenience. Companies in other regions have developed telemedicine platforms focusing on specific health concerns, but Fellos distinguishes itself by exclusively targeting men’s health issues within the Dutch healthcare system. The rising trend of online healthcare platforms has demonstrated the potential to alleviate pressure on traditional medical services, making digital clinics an increasingly viable solution.
Who Invested in Fellos?
The funding round attracted contributions from several investors, including experienced pharmacy entrepreneurs, a well-known e-commerce entrepreneur, and Dutch Operator Fund I, which consists of seven seasoned entrepreneurs and angel investors. The investors recognized the platform’s potential to address a growing healthcare need.
“After assessing more than 250 pitches since the launch, Fellos is our first investment. The team has not only created a strong product but also responds to a clear need in the market,” said Jeroen Bertrams, one of the initiators of Dutch Operator Fund I.
How Will the Funding Be Used?
Fellos intends to use the investment to advance the development of its healthcare platform, making digital consultations and treatments more efficient. The company aims to scale its services while maintaining high-quality care for its users.
“The rapid growth of our healthcare platform proves that there is a demand among men for a place where they can go for care in an accessible way,” stated Rob Smeitink, co-founder of Fellos.
The investment will also contribute to making digital healthcare more accessible for men hesitant to visit a general practitioner for specific concerns. Fellos emphasizes that its services complement, rather than replace, conventional medical care.
“We offer men who previously avoided their GP an alternative, in which the quality of care remains paramount. Fellos is also not a replacement for the current healthcare provision, but an addition,” added Smeitink.
The increasing demand for digital healthcare solutions highlights a shift in patient preferences toward more flexible and discreet medical consultations. While traditional healthcare settings remain essential, digital clinics help mitigate long waiting times and reduce the strain on general practitioners. The success of Fellos suggests that specialized digital health platforms could become a more prominent part of the healthcare landscape, particularly in addressing conditions that patients may be reluctant to discuss in person. As telemedicine continues to evolve, its role in supplementing standard medical care is expected to grow.
